Retractable Technologies, Inc. (RVP) Fair Value 2026

RVP · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 2 models active

Value Trap Risk

WARN (53/100)

Quick Summary — As of 2026-08-28, Retractable Technologies, Inc. (RVP) trades at $0.73, versus a $0.33 median fair value across its 2 active models — 54.9% below the current price. QOC: 6.2/10. Value Trap Risk: 53/100 (WARN). 2/13 models active.

Key Facts

Ticker
RVP
Price
$0.73
Quality Score
6.2/10
Value Trap Risk
53/100
Models Active
2/13
Last Updated
Strength: 2 independent models provide multi-angle coverage
Risk: Value Trap score of 53 suggests caution despite apparent undervaluation

Is Retractable Technologies, Inc. (RVP) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Retractable Technologies, Inc. (RVP) appears overvalued as of : the median of 2 independent fair value estimates is $0.33, 54.9% below the current price of $0.73. Estimates range from $0.05 to $0.61. RVP scores 6.2/10 on fundamental quality and 53/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. RVP’s -54.9% gap is wider than that market norm, and the Medical Instruments & Supplies sector median is -29.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Retractable Technologies, Inc. Stock in 2026? →

What Fair Value Does Each Model Give RVP?

2 Intrinsic Value Models vs. Current Price ($0.73)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · Medium Conviction
 $0.05 -93.0%
Asset-Based · High Conviction
 $0.61 -16.8%

All Models Active

All 2 models are displayed above.

What Is Retractable Technologies, Inc. (RVP) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Retractable Technologies, Inc.'s intrinsic value is estimated at $0.33. Trading at its current price of $0.73, the valuation engine raises significant caution: 2 of 2 models flag downside risk, projecting a median implied return of -54.9%. Model dispersion is worth noting: Dynamic NAV targets $0.61 (-16.8%), versus EPV at $0.05 (-93.0%). This +76.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About RVP?

2 of 13 models are currently active for RVP. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for RVP is $0.33 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does RVP Rank in Medical Instruments & Supplies?

Among 56 Medical Instruments & Supplies stocks, RVP ranks #35 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

See all Most Undervalued Medical Instruments & Supplies Stocks →

Retractable Technologies, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is RVP a Value Trap?

CirclFi's Value Trap algorithm assigns RVP a score of 53/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Retractable Technologies, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Retractable Technologies, Inc. earns a quality score of 6.2/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.

The gap between the most bullish and bearish model spans +76.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every RVP valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across RVP's 2 active models, average confidence is 38%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Retractable Technologies, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

TFXTeleflex IncorporatedQOC 6.2MLSSMilestone Scientific Inc.QOC 6.2BLCOBausch + Lomb CorporationQOC 6.3POCIPrecision Optics Corporation, Inc.QOC 6.1MMEDMiniMed Group, Inc.QOC 6.3XRAYDENTSPLY SIRONA Inc.QOC 6.1DXRDaxor CorporationQOC 4.6COOThe Cooper Companies, Inc.QOC 8.5SOLVSolventum CorporationQOC 7.2ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: TFX · MLSS · BLCO · POCI · MMED · XRAY · DXR · COO · SOLV · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to RVP?

7 companies across all industries closest to RVP’s Quality of Company score of 6.2/10.

IHRTiHeartMedia, Inc.QOC 6.2MGNXMacroGenics, Inc.QOC 6.2WHFWhiteHorse Finance, Inc.QOC 6.2CVRXCVRx, Inc.QOC 6.2COLDAmericold Realty Trust, Inc.QOC 6.2NWENorthWestern Energy Group, Inc.QOC 6.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: IHRT · MGNX · WHF · CVRX · COLD · NWE · NVDA

Where Does RVP Sit in CirclFi's Medical Instruments & Supplies Rankings?

RVP is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About Retractable Technologies, Inc.’s Valuation?

What is Retractable Technologies, Inc.'s intrinsic value in 2026?

CirclFi puts Retractable Technologies, Inc. (RVP)'s intrinsic value at $0.33 — the median of 2 independent model estimates as of 2026-08-28, ranging from $0.05 to $0.61. The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is RVP overvalued or undervalued right now?

At $0.73, 0 of 2 active models suggest RVP may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $0.33, 54.9% below the current price of $0.73 — a consensus view that RVP is overvalued. The assessment depends on which methodology best fits Retractable Technologies, Inc.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 6.2 mean for RVP?

Retractable Technologies, Inc.'s QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on RVP?

CirclFi analyzes RVP with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is RVP a value trap in 2026?

Retractable Technologies, Inc.'s Value Trap score is 53/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Retractable Technologies, Inc. (RVP) has a median fair value of $0.33 — 54.9% below the current price of $0.73 — as of 2026-08-28.” Source: circlfi.com/stock/RVP/ · Methodology
Primary sources for this RVP valuation
  • Financial statements: Retractable Technologies, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000946563) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for RVP as of ; valuations recomputed .